CS
WST icon

Cannell & Spears’s West Pharmaceutical WST Stock Holding History

Cannell & Spears’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-535
Closed -$220K – 228
2022
Q1 		$220K Buy
+535
New +$209K 0.02% 212
2014
Q4 		– Sell
-8,670
Closed -$388K – 147
2014
Q3 		$388K Buy
8,670
+462
+6% +$19.6K 0.05% 102
2014
Q2 		$346K Buy
+8,208
New +$352K 0.04% 110

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Cannell & Spears's WST Position: Q2 2022 in Review

Cannell & Spears sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 535 shares — an estimated $220K sold.

Cannell & Spears first reported a position in WST in Q2 2014 and held it in 3 quarters. The position peaked at $388K in Q3 2014. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Cannell & Spears reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Cannell & Spears sold 535 West Pharmaceutical shares in Q2 2022, an estimated $220K.
  • Cannell & Spears first reported a position in West Pharmaceutical in Q2 2014 and held it in 3 quarters.
  • Cannell & Spears's West Pharmaceutical position peaked at $388K in Q3 2014.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Cannell & Spears's 13F filing for Q2 2022, filed 8 Aug 2022.